Recent studies indicate that increased expression of α-synuclein in MSA oligodendroglia [7;8] may trigger the pathological aggregation of the protein in these cells and the following neurodegenerative events that bring forward selective neuronal loss resulting in the clinical symptoms of MSA. This evidence concerns the gene SNCA and multiple system atrophy.